Subscribe to RSS
DOI: 10.1055/s-2006-933136
2-Alkylidene-4-oxothiazolidine Vinyl Bromides: Versatile Precursors for C(5) Functionalization via Pyridine-Assisted Bromine Transfer
Publication History
Publication Date:
09 March 2006 (online)
Abstract
A series of structurally diverse vinyl bromides, derived from push-pull 2-alkylidene-4-oxothiazolidines, undergoes pyridine-assisted bromine transfer from the C=C bond to the C(5) position, enabling different C(5) functionalization. The type of the product depends on the C(5) substituent and, in some cases, the transformation is affected by the substituent at the C=C bond.
Key words
push-pull alkenes - 2-alkylidene-4-oxothiazolidines - pyridine - bromine transfer - functionalization
- 1
Pontillo J.Chen C. Bioorg. Med. Chem. Lett. 2005, 15: 1407 - 2
Bellur E.Langer P. Synlett 2004, 2169 - 3
Kulesza A.Ebetino FH.Mishra RK.Cross-Doersen D.Mazur AW. Org. Lett. 2003, 5: 1163 - 4
Foote KM.Hayes CJ.John MP.Pattenden G. Org. Biomol. Chem. 2003, 1: 3917 - 5
Kuethe JT.Wong A.Wu J.Davies IW.Dormer PG.Welch CJ.Hillier MC. J. Org. Chem. 2002, 67: 5993 - 6
Rossi R.Bellina F.Carpita A. Synlett 1996, 356 - 7
Torri S.Xu LH.Okumoto H. Synlett 1991, 695 - 8
Cocco MT.Congiu C.Onnis V.Ianelli S. Heterocycles 2004, 63: 259 - 9
Kameswaran V.Jiang B. Synthesis 1997, 530 - 10
Akiyama T.Simeno F.Murakami M.Yoneda F. J. Am. Chem. Soc. 1992, 114: 6613 - 11
Singh G.Ila H.Junjappa H. Synthesis 1985, 165 - 12
Haddad N.Abramovich Z.Ruhman I. Tetrahedron Lett. 1996, 37: 3521 - 13
Seebach D.Gysel U.Job K.Beck AK. Synthesis 1992, 39 - 14
Medici A.Fogagnolo M.Pedrini P.Dondoni A. J. Org. Chem. 1982, 47: 3844 - 15
Marković R.Baranac M. Synlett 2000, 607 - 16
Marković R.D˛ambaski Z.Baranac M. Tetrahedron 2001, 57: 5833 - 17
Maki J.Sako M.Tanabe M.Suzuki M. Synthesis 1981, 462 - 19
Satzinger G. Justus Liebigs Ann. Chem. 1963, 665: 150 - 20
Satzinger G. Liebigs Ann. Chem. 1978, 473 - 21
Zaleska B.Ciez D.Winnik W.Chaczatrion K. Pharmazie 1995, 50: 537 - 22
Baranac M. PhD Thesis University of Belgrade; Serbia and Montenegro: 2005. - 24
Marković R.Pavlovich JG.Baranac M. Phosphorus, Sulfur Silicon Relat. Elem. 2005, 180: 1411 - 25
Hutchinson REJ.Tarbell DS. J. Org. Chem. 1969, 34: 66 - 26
Lane TH.Speier JL. Org. Chem. 1976, 41: 2714 - 27
Anders E.Hertlein K.Meske H. Synthesis 1990, 323 - 28
Katritzky AR.Marson CM. Angew. Chem., Int. Ed. Engl. 1984, 23: 420 ; and references cited therein - 30
Katritzky AR.Bapat JB.Blade RJ.Leddy BP.Nie P.-L.Ramsden CA.Thind SS. J. Chem. Soc., Perkin Trans. 1 1979, 418 - 31
Gromov SP.Kurchavov NA. Eur. J. Org. Chem. 2002, 4123 - 32
Van der Plas HC. J. Heterocycl. Chem. 2000, 37: 427
References and Notes
Typical Procedure for Synthesis of 2-Bromo-2-(4-oxo-thiazolidin-2-ylidene)-
N
-(2-phenylethyl)ethanamide (
5b).
To a suspension of 1 mmol of the parent 4-oxothiazolidine in CHCl3 (37 mL) 2% bromine solution in the same solvent (ca. 1 equiv of bromine) was added dropwise under reflux until complete disappearance of the starting material. The progress of the reaction was monitored by TLC. The reaction mixture was evaporated to dryness, EtOH (2-3 mL) and a few drops of H2O were added and bromide was allowed to crystallize in a freezer. In the case of preparation of vinyl bromides 6a-e, EtOH (50 mL) was used as a solvent and bromine addition was carried out at ca. -5 °C. The reaction mixture was evaporated to several mL, a certain amount of H2O was added and bromides were allowed to crystallize in a freezer. Only vinyl bromide 6b was isolated by extraction with CH2Cl2 and could not be crystallized. All crystallized vinyl bromides 5a-e and 6a-e were isolated as pure substances.
Spectroscopic Data for (Z)- and (E)-5b.
1H NMR (200 MHz, DMSO-d
6): δ (Z isomer) = 2.78 (t, 2 H, CH2Ph, J = 7.3 Hz), 3.33-3.43 (m, 2 H, NCH2), 3.95 (s, 2 H, CH2S), 7.19-7.34 (m, 5 H, Ph), 7.84 (t, 1 H, NHamide, J = 5.6 Hz), 11.37 (s, 1 H, NHlactam); δ (E-isomer) = CH2Ph and NCH2 are shielded, 3.79 (s, 2 H, CH2S), Ph is shielded, 7.17 (t, 1 H, NHamide, J = 5.2 Hz), 10.93 (s, 1 H, NHlactam). 13C NMR (50.3 MHz, DMSO-d
6
): δ (Z-isomer) = 33.2 (CH2S), 35.1 (CH2Ph), 41.4 (NCH2), 84.2 (=CBr), 126.3 (p-Ph), 128.6 (o-Ph), 128.8 (m-Ph), 139.4 (C1-Ph), 152.8 (C=), 163.3 (COamide), 173.3 (COlactam); δ (E isomer) = 33.8 (CH2S), 35.4 (CH2Ph), 41.4 (NCH2), 80.0 (=CBr), 126.3 (p-Ph), 128.6 (o-Ph), 128.8 (m-Ph), 139.4 (C1-Ph), 149.9 (C=), 163.3 (COamide), 174.3 (COlactam). IR (KBr, Z and E): ν = 3360, 3139, 3022, 1723, 1615, 1585, 1517, 1452, 1431, 1350, 1312, 1257, 1219, 1190, 887, 786, 750, 699 cm-1. MS (CI): m/z = 341/343 [M + 1]. UV (DMSO, Z and E): λmax (ε) = 296.6 nm (18.900). Anal. Calcd for C13H13BrN2O2S: C, 45.76; H, 3.84; N, 8.21; S, 9.40. Found: C, 45.94; H, 3.90; N, 8.16; S, 9.56.
Typical Procedure for Synthesis of ( Z )-[4-Oxo-5-(pyr-idinium-1-yl)thiazolidin-2-ylidene] -N -(2-phenyl-ethyl)ethanamide Bromide ( 7b) by Pyridine-Assisted Bromine Transfer Reaction. To a suspension of 1.48 mmol of vinyl bromide 5b (0.505 g) in CHCl3 (31 mL) a tenfold molar excess of pyridine was added and mixture refluxed for 7 d. Reaction mixture was then cooled to r.t. and evaporated to dryness under reduced pressure. Column chromatography (SiO2, MeOH as an eluent) of the crude product yielded 7b (0.541 g, 87%) as a pale brown solid. 1H NMR (200 MHz, DMSO-d 6): δ = 2.75 (t, 2 H, CH2Ph, J = 7.2 Hz), 3.31-3.40 (m, 2 H, NCH2), 5.94 (s, 1 H, =CH), 7.09 (s, 1 H, CHS), 7.17-7.35 (m, 5 H, Ph), 8.24 (t, 2 H, m-pyridine, J = 7.2 Hz), 8.33 (t, 1 H, NHamide, J = 5.4 Hz), 8.75 (t, 1 H, p-pyridine, J = 7.8 Hz), 9.30 (d, 2 H, o-pyridine, J = 5.6 Hz), 12.30 (br s, 1 H, NHlactam). 13C NMR (50.3 MHz, DMSO-d 6): δ = 35.4 (CH2Ph), 40.4 (NCH2), 71.8 (CHS), 96.5 (=CH), 126.4 (p-Ph), 128.6 (o-Ph), 128.7 (m-pyridine), 128.9 (m-Ph), 139.7 (C1-Ph), 144.8 (o-pyridine), 146.3 (C=), 148.0 (p-pyridine), 166.4 (COamide), 168.2 (COlactam). IR (KBr): ν = 3271, 3051, 3025, 1722, 1656, 1597, 1545, 1484, 1448, 1298, 1246, 1198, 1173, 832, 754, 703 cm-1. ESI-MS: m/z 340 [M+], 261.
29Typical Procedure for Synthesis of ( Z , E )-(5-Morpholino-4-oxothiazolidin-2-ylidene)- N -(2-phenylethyl)ethan-amide ( 9b). A mixture of the crude pyridinium salt 7b (94.3 mg) and morpholine (0.08 mL, 0.91 mmol) in CHCl3 (8.7 mL) was stirred at r.t. for 6.5 h in dry atmosphere. After evaporation of the solvent under reduced pressure, the residue was purified by column chromatography (SiO2, gradient toluene-EtOAc, 4:6 v/v to pure EtOAc) to give a pale yellow solid as a mixture of isomers (Z)- and (E)-9b (69.4 mg, 87% based on vinyl bromide 5b). 1H NMR (200 MHz, DMSO-d 6): δ (Z isomer) = 2.24-2.30 (m, 2 H, NCHax), 2.62-2.74 (m, 4 H, NCHeq and CH2Ph), 3.24-3.34 (m, 2 H, NCH2), 3.57-3.60 (m, 4 H, CH2O), 5.30 (s, 1 H, CHS), 5.58 (s, 1 H, =CH), 7.16-7.34 (m, 5 H, Ph), 7.90 (t, 1 H, NHamide, J = 5.5 Hz), 11.42 (s, 1 H, NHlactam); δ (E isomer) = 2.21-2.31 (m, 2 H, NCHax), 2.57-2.76 (m, 4 H, NCHeq and CH2Ph), NCH2 is shielded, 3.61 (t, 4 H, CH2O, J = 4.4 Hz), 5.23 (s, 1 H, =CH), 5.72 (s, 1 H, CHS), 7.16-7.34 (m, 5 H, Ph), 8.02 (t, 1 H, NHamide, J = 5.6 Hz), 11.70 (s, 1 H, NHlactam). 13C NMR (50.3 MHz, DMSO-d 6): δ (Z isomer) = 35.6 (CH2Ph), 40.4 (NHCH2), 48.4 (CH2N), 65.9 (CH2O), 72.6 (CHS), 94.5 (=CH), 126.3 (p-Ph), 128.6 (o-Ph), 128.8 (m-Ph), 139.8 (C1-Ph), 148.1 (C=), 166.3 (COamide), 171.7 (COlactam); δ (E isomer) = 35.3 (CH2Ph), 40.3 (NHCH2), 48.6 (CH2N), 65.8 (CH2O), 75.1 (CHS), 92.7 (=CH), 126.4 (p-Ph), 128.6 (o-Ph), 128.8 (m-Ph), 139.6 (C1-Ph), 147.7 (C=), 166.8 (COamide), 170.0 (COlactam). IR (KBr, Z and E): ν = 3437, 3267, 3212, 3077, 1718, 1635, 1565, 1454, 1280, 1249, 1113, 858, 831, 768, 703 cm-1. MS (CI): m/z 348 [M + 1]. UV (DMSO, Z and E): λmax (ε) = 283.8 nm (25.700). Anal. Calcd for C17H23N3O4S (9b·H2O): C, 55.87; H, 6.34; N, 11.50; S, 8.77. Found: C, 55.90; H, 6.34; N, 11.42; S, 9.05.